Join
Live feed
·
PRReleasevia Quantisnow
cbdMD Inc. logo

cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways

ByQuantisnow·Wall Street's wire, on your screen.
YCBD· cbdMD Inc.
Consumer Discretionary

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track YCBD (cbdMD Inc.) and more on Quantisnow.